Agree about cash position, gives us only another 6months maximum, although ALT has so far been able to remain debt free, which is a positive.
A few further unrelated points I've been mulling over lately. Feel free to post your opinions.
* recent capital raise did not involve most shareholders so anyone waiting to average down with discounted shares will have to now buy on market.
* 300,000 pelvic floor related operations performed in USA alone per annum. Pericoach becomes prior or adjunct treatment for surgery then pharma can charge what they like..... eg $1000 per unit as opposed to our current $300 price... especially if health insurance is involved. And, particularly if Pericoach is recommended as the treatment required prior to approval for an operation...
ALT Price at posting:
0.7¢ Sentiment: Hold Disclosure: Held
